🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Pulmonary Tuberculosis

DoseTB-individualised Dosing by Model-informed Precision Dosing for Pulmonary Tuberculosis NCT06585358n/a2 sites📍 Linköping📍 Stockholm Karolinska Institutet · Tests: MIPD Tuberculosis Cohort Avicenne Hospital NCT05539014n/a2 sites📍 Bobigny📍 Bobigny Assistance Publique - Hôpitaux de Paris · Tests: Data collection A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis NCT07209761Phase 342 sites📍 Beijing📍 Fuzhou📍 Shenzhen Otsuka Pharmaceutical Development & Commercialization, Inc. · Tests: Bedaquiline, Quabodepistat, Pretomanid, Moxifloxacin, Linezolid Cellular Markers in Treated or Untreated Non-tuberculous Mycobacterial Respiratory Infection in Patients With Cystic Fibrosis NCT06602869n/a1 site📍 Montpellier University Hospital, Montpellier · Tests: Scheduled visit (V1) Lung Innate Immunity and Microbiome After Tuberculosis Exposure NCT06526689n/a3 sites📍 Oxford📍 Oxford📍 London University of Oxford Blood Tuberculosis DNA Levels to Monitor Tuberculosis Treatment NCT06845618n/a1 site📍 Tak University of Oxford Fibroblast Activating Protein (FAP) PET/CT in Adults With Tuberculosis NCT07830771EARLY Phase 11 site📍 Philadelphia University of Pennsylvania · Tests: [18F]-FAPI-74 Mediastinal EBUS Cryobiopsy Study In Sweden NCT06347939n/a2 sites📍 Lund📍 Umeå Region Skane · Tests: Mediastinal lymph nodes cryobiopsies Identification of New Biological Markers for the Progression of Mycobacterium Abscessus-induced Lung Disease in Cystic Fibrosis NCT06413459n/a1 site📍 Milan Ospedale San Raffaele · Tests: Luminex; scRNAsec Safety and Efficacy of Ear Acupuncture for Antituberculosis Drug-Related Nausea and Vomiting NCT07271225NA1 site📍 Jakarta Universitas Indonesia · Tests: Press Needle, Sham Press Needle Effect of Peer-led Educational Intervention on Treatment Outcomes Among Adults With Drug-susceptible Pulmonary Tuberculosis in South Omo and Ari Zone, Southern Ethiopia NCT07387601NA1 site📍 Jinka Bahirdar University · Tests: peer-led education Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis NCT05473520Phase 36 sites📍 Kota Kinabalu📍 Kota Kinabalu📍 Kota Kinabalu National University Hospital, Singapore · Tests: Doxycycline, Placebo ID93+GLA-SE Vaccine Against Tuberculosis in Older Adults Aged 55-74 NCT06714513Phase 14 sites📍 Gwangmyeong📍 Seoul📍 Seoul Quratis Inc. · Tests: QTP101, Placebo Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure) NCT07164742NA2 sites📍 Mangalore📍 Pune Johns Hopkins University · Tests: 8 week (short arm) Intervention - pulmonary rehabilitation, 24 week (long arm) Intervention - pulmonary rehabilitation Effects of Adjunct Omega-3 Long Chain Polyunsaturated Fatty Acids in Pulmonary Tuberculosis Patient: an Early Bactericidal Activity and Inflammatory Trial NCT07118059Phase 21 site📍 Klerksdorp North-West University, South Africa · Tests: Omega-3 (EPA+DHA), Placebo 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis Patients NCT07077213n/a1 site📍 Cincinnati Children's Hospital Medical Center, Cincinnati · Tests: 18F-FAPI-74 PanACEA - STEP2C -01 NCT05807399Phase 210 sites📍 Lambaréné📍 Blantyre📍 Maputo Michael Hoelscher · Tests: BTZ-043, Rifampicin, Isoniazid, Pyrazinamide, Moxifloxacin LIFE-TB ; Long-Term Impacts on Lung Health and Life After Tuberculosis in Korea NCT06946784n/a1 site📍 Seoul Yonsei University Short-term Antibiotic Therapy in Mycobacterium Avium Complex Pulmonary Disease NCT07213765Phase 46 sites📍 Hefei📍 Beijing📍 Beijing Bin Cao · Tests: Contezolid, Azithromycin, Azithromycin, Ethambutol (E), Ethambutol (E) Remimazolam for Bronchoscopy in High-Risk Patients NCT07395596Phase 42 sites📍 Hangzhou📍 Shaoxing First Affiliated Hospital of Zhejiang University · Tests: propofol and alfentanil, remimazolam combined with propofol and alfentanil Channa Striata and Curcuma Domestica Supplementation in Patients With Active Pulmonary Tuberculosis NCT07887724NA2 sites📍 Medan📍 Medan DINA KEUMALA SARI · Tests: CHANA STRIATA AND CURCUMA, Maltodextrin (Placebo) Pragmatic Optimized Rifampicin Trial NCT06057519Phase 32 sites📍 Turin📍 Nijmegen Radboud University Medical Center · Tests: Optimised dose rifampicin, Standard dose rifampicin A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets NCT07170800Phase 27 sites📍 Wuhan📍 Changsha📍 Nanjing WestVac Biopharma Co., Ltd. · Tests: JDB0131 100mg, JDB0131 200mg, Delamanid (D) Improving the Outcomes of Children With Tuberculosis Through Innovative Diagnostics and Treatment Monitoring NCT06815588n/a1 site📍 Bucharest Research Center Borstel Phase 2 Trial to Evaluate the Safety and Tolerability and Early Bactericidal Activity of RESP30TB in Tuberculosis NCT07073638Phase 21 site📍 Cape Town Thirty Respiratory Limited · Tests: RESP30TB, HRZE (Rifampicin, Isoniazid, Pyrazinamide, Ethambutol combination) Shortened Regimen for Drug-susceptible TB in Children NCT06253715Phase 39 sites📍 Chennai📍 Pune📍 Bandung Johns Hopkins University · Tests: Isoniazid, Rifampin, Pyrazinamide, Ethambutol, Rifapentine A PAN-USR TB Multi-Center Trial NCT06905522Phase 33 sites📍 Beijing📍 Shenzhen📍 Ürümqi Shenzhen Third People's Hospital · Tests: Bedaquiline (B), Sitafloxacin (S), Linezolid (L), Pyrazinamide (Z), Isoniazid (H) Treatment Monitoring for NTM Infections With a Symptom Diary NCT07131774n/a3 sites📍 Freiburg im Breisgau📍 Frankfurt am Main📍 Borstel Research Center Borstel · Tests: Filling in a symptom diary Prevalence of Latent Tuberculosis Infection in Health-care Workers and Students NCT05756582n/a1 site📍 Roma Eleonora Nucera · Tests: Prevalence of Latent Tuberculosis Infection Bactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary Tuberculosis NCT07525427Phase 213 sites📍 Durban📍 George📍 Johannesburg Gates Medical Research Institute · Tests: Bedaquiline, pretomanid and TBD09, Bedaquiline, pretomanid and TBD09, Bedaquiline, pretomanid and TBD09, Bedaquiline, p…
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy